CD28 and neoplasm: MDSCs correlate with tumor metastasis. Inhibition of CFSE-labeled autologous CD3+ T cell proliferation at 2:1 ratios with MDSCs in the absence or presence of CD3/CD28 antibody stimulation for 3 days.